1022 related articles for article (PubMed ID: 18409523)
1. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
Fujimori S
Nihon Rinsho; 2008 Apr; 66(4):729-35. PubMed ID: 18409523
[TBL] [Abstract][Full Text] [Related]
2. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
[TBL] [Abstract][Full Text] [Related]
3. A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis.
Perez-Ruiz F; Herrero-Beites AM; Carmona L
Arthritis Rheum; 2011 Dec; 63(12):4002-6. PubMed ID: 21898351
[TBL] [Abstract][Full Text] [Related]
4. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of combination treatment using allopurinol and benzbromarone for gout and hyperuricemia accompanying renal dysfunction: kinetic analysis of oxypurinol].
Ohno I; Okabe H; Yamaguchi Y; Saikawa H; Uetake D; Hikita M; Gomi H; Ichida K; Hosoya T
Nihon Jinzo Gakkai Shi; 2008; 50(4):506-12. PubMed ID: 18546882
[TBL] [Abstract][Full Text] [Related]
6. What do I need to know about gout?
Becker MA; Ruoff GE
J Fam Pract; 2010 Jun; 59(6 Suppl):S1-8. PubMed ID: 20544070
[TBL] [Abstract][Full Text] [Related]
7. 2011 Recommendations for the diagnosis and management of gout and hyperuricemia.
Hamburger M; Baraf HS; Adamson TC; Basile J; Bass L; Cole B; Doghramji PP; Guadagnoli GA; Hamburger F; Harford R; Lieberman JA; Mandel DR; Mandelbrot DA; McClain BP; Mizuno E; Morton AH; Mount DB; Pope RS; Rosenthal KG; Setoodeh K; Skosey JL; Edwards NL;
Postgrad Med; 2011 Nov; 123(6 Suppl 1):3-36. PubMed ID: 22156509
[TBL] [Abstract][Full Text] [Related]
8. CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.
Bakris GL; Doghramji PP; Keenan RT; Silber SH
Am J Med; 2014 Jan; 127(1):S1. PubMed ID: 24268074
[TBL] [Abstract][Full Text] [Related]
9. [How to select and use urate lowering agents for hyperuricemia].
Yamanaka H
Nihon Rinsho; 1996 Dec; 54(12):3261-5. PubMed ID: 8976102
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic approaches to chronic hyperuricemia and gout.
Grassi D; Pontremoli R; Bocale R; Ferri C; Desideri G
High Blood Press Cardiovasc Prev; 2014 Dec; 21(4):243-50. PubMed ID: 24696068
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.
Reinders MK; van Roon EN; Jansen TL; Delsing J; Griep EN; Hoekstra M; van de Laar MA; Brouwers JR
Ann Rheum Dis; 2009 Jan; 68(1):51-6. PubMed ID: 18250112
[TBL] [Abstract][Full Text] [Related]
12. Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trials.
Wortmann RL; Macdonald PA; Hunt B; Jackson RL
Clin Ther; 2010 Dec; 32(14):2386-97. PubMed ID: 21353107
[TBL] [Abstract][Full Text] [Related]
13. Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
Chohan S; Becker MA; MacDonald PA; Chefo S; Jackson RL
Arthritis Care Res (Hoboken); 2012 Feb; 64(2):256-61. PubMed ID: 22052584
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.
Becker MA; Schumacher HR; MacDonald PA; Lloyd E; Lademacher C
J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847
[TBL] [Abstract][Full Text] [Related]
15. Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events.
Dalbeth N; Stamp L
Semin Dial; 2007; 20(5):391-5. PubMed ID: 17897242
[TBL] [Abstract][Full Text] [Related]
16. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
Dalbeth N; Kumar S; Stamp L; Gow P
J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hyperuricemia, gout and other crystalline arthritidies.
Lioté F
Reumatismo; 2012 Jan; 63(4):276-83. PubMed ID: 22303534
[TBL] [Abstract][Full Text] [Related]
18. [Hyperuricemia].
Chizyński K; Rózycka M
Pol Merkur Lekarski; 2005 Nov; 19(113):693-6. PubMed ID: 16498814
[TBL] [Abstract][Full Text] [Related]
19. Long-term management of gout: nonpharmacologic and pharmacologic therapies.
Chaichian Y; Chohan S; Becker MA
Rheum Dis Clin North Am; 2014 May; 40(2):357-74. PubMed ID: 24703352
[TBL] [Abstract][Full Text] [Related]
20. Gout: an update.
Eggebeen AT
Am Fam Physician; 2007 Sep; 76(6):801-8. PubMed ID: 17910294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
